Australia's most trusted
source of pharma news
Saturday, 21 December 2024
Posted 20 December 2024 AM
In a year of belt-tightening and downsizing, it's no surprise that half of the Pharma in Focus Top 10 stories of 2024 related to redundancies and restructures.
But there was also strong interest in salaries with two of the Top 10 stories taking a deep dive into how much pharma professionals earn. The hottest career in pharma plus an eye-watering $22M fine for a TGA breach also prompted plenty of clicks.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.